These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15642867)

  • 1. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders: where is the evidence?
    Janssens AC
    Arch Neurol; 2005 Jan; 62(1):164; author reply 164. PubMed ID: 15642867
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders.
    Smith CO; Lipe HP; Bird TD
    Arch Neurol; 2004 Jun; 61(6):875-80. PubMed ID: 15210524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Informed consent to the patient with hereditary ataxia].
    Takayanagi T; Matumura R; Murata K
    No To Shinkei; 1996 May; 48(5):437-42. PubMed ID: 8672302
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and management of early- and late-onset cerebellar ataxia.
    Brusse E; Maat-Kievit JA; van Swieten JC
    Clin Genet; 2007 Jan; 71(1):12-24. PubMed ID: 17204042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Japanese family with early-onset ataxia with motor and sensory neuropathy.
    Kobayashi S; Takuma H; Murayama S; Sakurai M; Kanazawa I
    J Neurol Sci; 2007 Mar; 254(1-2):44-8. PubMed ID: 17258771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Triplet repeat disorders: from the clinical view].
    Komure O; Ueno S; Sano A
    Tanpakushitsu Kakusan Koso; 1997 Aug; 42(11):1840-57. PubMed ID: 9279119
    [No Abstract]   [Full Text] [Related]  

  • 7. [Presymptomatic DNA diagnosis of spinocerebellar ataxia type 1].
    Illarioshkin SN; Ivanova-Smolenskaia IA; Limborskaia SA; Ovchinnikov IV; Markova ED; Slominskiĭ PA; Kliushnikov SA; Miklina NI
    Genetika; 1997 May; 33(5):693-8. PubMed ID: 9273319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triplet repeats in neuromuscular disorders.
    Boucher C; Johnson K
    Ann Med; 1995 Feb; 27(1):3-5. PubMed ID: 7741996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic testing for neuromuscular disorders].
    Yoshida K
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():183-9. PubMed ID: 16416792
    [No Abstract]   [Full Text] [Related]  

  • 10. Hereditary episodic ataxias.
    Jen JC
    Ann N Y Acad Sci; 2008 Oct; 1142():250-3. PubMed ID: 18990130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hereditary neuromuscular diseases in paediatrics. Our experience over the last 14 years].
    López-Pisón J; Rebage V; Baldellou-Vázquez A; Capablo-Liesa JL; Colomer J; Calvo MT; Sáenz de Cabezón A; Alfaro-Torres J; del Agua C; Bestué M; Peña-Segura JL
    Rev Neurol; 2005 Aug 1-15; 41(3):145-50. PubMed ID: 16047297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [National survey of presymptomatic genetic testing for adult-onset hereditary neuromuscular diseases-system development for after the establishment of therapies].
    Shibata Y; Matsushima M; Kato M; Chang H; Nakamura K; Oda K; Yoshida K; Sekijima Y; Toda T; Yabe I
    Rinsho Shinkeigaku; 2022 Oct; 62(10):773-780. PubMed ID: 36184415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breaks in coordination: DNA repair in inherited ataxia.
    Paulson HL; Miller VM
    Neuron; 2005 Jun; 46(6):845-8. PubMed ID: 15953413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary ataxia and behavior.
    Alekseeva N; Kablinger AS; Pinkston J; Gonzalez-Toledo EC; Minagar A
    Adv Neurol; 2005; 96():275-83. PubMed ID: 16383226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent clinical advances in hereditary spinocerebellar degeneration].
    Yabe I
    Rinsho Shinkeigaku; 2024 Mar; 64(3):135-147. PubMed ID: 38382935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic diagnosis of hereditary spinocerebellar degeneration].
    Ikeuchi T; Tsuji S
    Nihon Naika Gakkai Zasshi; 1994 Nov; 83(11):2000-6. PubMed ID: 7852812
    [No Abstract]   [Full Text] [Related]  

  • 17. [Present condition and problem of presymptomatic genetic testing].
    Kukinaka C
    Rinsho Shinkeigaku; 2013; 53(11):1003-5. PubMed ID: 24291860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel mutations by targeted NGS in Moroccan families clinically diagnosed with a neuromuscular disorder.
    Rochdi K; Cerino M; Da Silva N; Delague V; Bouzidi A; Nahili H; Zouiri G; Kriouile Y; Gorokhova S; Bartoli M; Saïle R; Barakat A; Krahn M
    Clin Chim Acta; 2022 Jan; 524():51-58. PubMed ID: 34852264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waiting for the family legacy: the experience of being at risk for Machado-Joseph disease.
    Boutté MI
    Soc Sci Med; 1990; 30(8):839-47. PubMed ID: 2315750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnosis of inheritable neuromuscular disorders. Part II: Application of genetic testing in neuromuscular disease.
    Greenberg SA; Walsh RJ
    Muscle Nerve; 2005 Apr; 31(4):431-51. PubMed ID: 15704143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.